Chinanews, Harbin, October 6th (Reporter Liu Xiju) On the 6th, the Harbin Municipal Health Commission issued a report on the epidemic situation in Harbin from 0-24 on October 5: From 0-24 on October 5, Harbin added overseas imports There was 1 confirmed case, 1 new local confirmed case of new coronary pneumonia (in Bayan County), and 1 new local confirmed case cured and discharged (Bayan County).
The aforementioned newly confirmed cases were discovered during the nucleic acid test during the isolation and observation period. The nucleic acid test result of the new coronavirus was positive and was transferred to a designated hospital for isolation and treatment in a closed loop. The expert team was based on the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition)" 》, combined with clinical and imaging findings and laboratory nucleic acid test results, it was diagnosed as a confirmed case of new coronary pneumonia.
Relevant departments have implemented isolation management and control measures for all close contacts and close contacts identified, and conducted follow-up inspections, closed management of the communities involved, and conducted terminal disinfection and closed management of the places where they had been active.
The main information of newly confirmed local cases on the day:
Confirmed case 88: A confirmed case of new coronary pneumonia (common type), currently living in Shenglong International, Bayan Town, Bayan County.
On October 5, a confirmed case of new coronary pneumonia admitted to Harbin City in the Qunli District of the First Hospital of Harbin Medical University (Provincial New Coronary Pneumonia Treatment Center), according to the "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Revised Edition)", After a comprehensive evaluation by the expert group, it has reached the discharge standard and was transferred to the second hospital of Harbin for rehabilitation treatment.
After recovery and discharge, isolation management, health monitoring, and follow-up visits will continue as required.
(over)